Showing results (1-10 of 704) with videos related to
Sort By:
Pageof 71
The New England Journal of Medicine|August 17, 2012
Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitisWilliam J Sandborn, Subrata Ghosh, Julian Panes, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 1, 2014
A phase 2 study of tofacitinib, an oral Janus kinase inhibitor, in patients with Crohn's diseaseWilliam J Sandborn, Subrata Ghosh, Julian Panes, et al.Gastroenterology|September 17, 2015
Correlation Between Concentrations of Fecal Calprotectin and Outcomes of Patients With Ulcerative Colitis in a Phase 2 TrialWilliam J Sandborn, Julian Panés, Haiying Zhang, et al.Clinical Pharmacology in Drug Development|January 29, 2021
Population Pharmacokinetics of Tofacitinib in Patients With Moderate to Severe Ulcerative ColitisCamille Vong, Steven W Martin, Chenhui Deng, et al.Clinical Pharmacology and Therapeutics|April 5, 2022
Exposure-Response Characterization of Tofacitinib Efficacy in Moderate to Severe Ulcerative Colitis: Results From Phase II and Phase III Induction and Maintenance StudiesArnab Mukherjee, Shinichi Tsuchiwata, Timothy Nicholas, et al.Therapeutic Advances in Gastroenterology|December 12, 2022
Modified Mayo score <i>versus</i> Mayo score for evaluation of treatment efficacy in patients with ulcerative colitis: data from the tofacitinib OCTAVE programWilliam J Sandborn, Bruce E Sands, Séverine Vermeire, et al.Inflammatory Bowel Diseases|April 25, 2006
Outcomes of placebo therapy in inflammatory bowel diseaseChinyu SuClinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 31, 2020
Efficacy and Safety of Extended Induction With Tofacitinib for the Treatment of Ulcerative ColitisWilliam J Sandborn, Laurent Peyrin-Biroulet, Daniel Quirk, et al.Current Drug Targets|April 2, 2016
Can we Monitor a Patient with Inflammatory Bowel Disease and Adapt Treatment without Endoscopy?Julian Panes, Elena RicartClinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 8, 2021
Efficacy and Safety of Tofacitinib in Ulcerative Colitis Based on Prior Tumor Necrosis Factor Inhibitor Failure StatusWilliam J Sandborn, Laurent Peyrin-Biroulet, Ala I Sharara, et al.Pageof 71